2. We further find that inductor angles in the range 15 degrees-25 degrees lead to joint side faces that are close to vertical. These findings are then verified experimentally by placing a liquid metal drop in a purpose built inductor of triangular cross-section. We find a good agreement
between the theoretical prediction of our two-dimensional Repotrectinib manufacturer model and the real three-dimensional drop. For the highest magnetic Bond number our generator could deliver, Bo(m)=20.19, we achieved a drop aspect ratio of 2.73. (C) 2010 American Institute of Physics. [doi:10.1063/1.3409075]“
“Objective-To evaluate the technical, short-term, and long-term outcomes in cats with benign ureteral obstructions treated by means of double-pigtail ureteral stent placement.
Design-Retrospective case series.
Animals-69 cats (79 ureters).
Procedures-The diagnosis of benign ureteral obstruction was made via abdominal ultrasonography, radiography, and ureteropyelography. Fedratinib clinical trial Ureteral stent placement was attempted endoscopically, surgically, or both, with fluoroscopic guidance. The medical records were reviewed for pre-, intra-, and postoperative data; complications; and outcome.
Results-69 cats (79 ureters) had stent placement attempted for various causes:
ureterolithiasis (56/79 [71%]), stricture (10/79 [13%]), both ureterolithiasis and stricture (12/79 [15%]), or a purulent plug (1/79 [1%]). Stent placement was successful in 75 of 79 ureters (95%). Median number of stones per ureter was 4 (range, CDK inhibitor drugs 0 to > 50), and 67 of 79 (85%) had concurrent nephrolithiasis. Preoperative azotemia was present in 95% (66/69) of cats (median creatinine concentration, 5.3 mg/dL [range, 1.1 to 25.8 mg/dL]), and 71% (49/69) remained azotemic (median, 2.1 mg/dL [range, 1.0 to 11.8 mg/dL]) after successful surgery. Procedure-related, postoperative (< 7 days), short-term
(7 to 30 days), and long-term (> 30 days) complications occurred in 8.7% (6/69; 7/79 ureters), 9.1% (6/66), 9.8% (6/61), and 33% (20/60) of cats, respectively; most of these complications were minor and associated with intermittent dysuria or the need for ureteral stent exchange. The perioperative mortality rate was 7.5% (5/69), and no deaths were procedure related. The median survival time was 498 days (range, 2 to > 1,278 days). For patients with a renal cause of death, median survival time was > 1,262 days, with only 14 of 66 cats (21%) dying of chronic kidney disease. Nineteen (27%) cats needed a stent exchange (stricture in-growth [n = 10], migration [4], ureteritis [2], dysuria [2], pyelonephritis [1] or reflux [1]). No patient died of the procedure or recurrent ureteral obstruction.